Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × Fulvestrant × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 116 Neoplasm Metastasis 16 Ovarian Neoplasms 13 Endometrial Neoplasms 9 Neoplasms 8 Triple Negative Breast Neoplasms 5 Prostatic Neoplasms 5 Uterine Cervical Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Advanced Breast Cancer 4 Neoplasms by Site 3 Hereditary Sensory and Autonomic Neuropathies 3 Head and Neck Neoplasms 3 Colorectal Neoplasms 3 Carcinoma, Ovarian Epithelial 3 Carcinoma, Non-Small-Cell Lung 3 Breast Diseases 3 Breast Cancer Metastatic 3 Stomach Neoplasms 2 Small Cell Lung Carcinoma 2 Recurrence 2 Multiple Endocrine Neoplasia Type 1 2 Melanoma 2 Fallopian Tube Neoplasms 2 Carcinoma, Lobular 2 Advanced Solid Tumors 2 Uterine Neoplasms 1 Urogenital Neoplasms 1 Urinary Bladder Neoplasms 1 Salivary Gland Neoplasms 1

Interventions

pembrolizumab 38 Gemcitabine 20 enfortumab vedotin 19 Cisplatin 17 Nivolumab 16 atezolizumab 14 Magnetic Resonance Spectroscopy 14 avelumab 13 Carboplatin 12 Specimen Handling 10 Docetaxel 10 sacituzumab govitecan 9 Paclitaxel 7 Ipilimumab 7 Fluorodeoxyglucose F18 5 pemigatinib 4 toripalimab 3 erdafitinib 3 durvalumab 3 cabozantinib 3 X-Rays 3 Taxes 3 Mitomycin 3 Immunoglobulin G 3 CTLA-4 Antigen 3 Biopsy 3 tislelizumab 2 lenvatinib 2 eribulin 2 dodecyl maltoside 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡